Literature DB >> 4038695

Acute effects of dexamethasone on intraocular pressure in glaucoma.

R N Weinreb, J R Polansky, S G Kramer, J D Baxter.   

Abstract

The effects of 3 mg orally administered dexamethasone on the intraocular pressure (IOP) were examined in four patients with primary open-angle glaucoma hospitalized for this study. Plasma-free glucocorticoid activity was measured by a radioreceptor assay. Diurnal rhythms of IOP and plasma-free glucocorticoid activity were detected prior to administration of dexamethasone. The plasma-free glucocorticoid activity rose two- to threefold in the 30-min period following steroid administration and then declined throughout the rest of the day. IOP was approximately 2 mmHg higher in the 0-4-hr period and approximately 5.5 mmHg higher in the 4-8-hr period following the pharmacologic doses of dexamethasone compared with similar periods on control days. The increase in the IOP was highly significant (P less than 0.006) in the latter time period. These findings suggest that the glucocorticoids may have a greater role in regulating IOP than generally has been appreciated.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4038695

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  25 in total

Review 1.  Locally administered ocular corticosteroids: benefits and risks.

Authors:  Charles N J McGhee; Simon Dean; Helen Danesh-Meyer
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 2.  Diurnal variations in intraocular pressure.

Authors:  J T Wilensky
Journal:  Trans Am Ophthalmol Soc       Date:  1991

3.  Cellular and cytoskeletal alterations of scleral fibroblasts in response to glucocorticoid steroids.

Authors:  Thania Bogarin; Sindhu Saraswathy; Goichi Akiyama; Xiaobin Xie; Robert N Weinreb; Jie Zheng; Alex S Huang
Journal:  Exp Eye Res       Date:  2019-08-23       Impact factor: 3.467

4.  [Preoperative therapy switch before glaucoma filtration surgery : Influence of the systemic antiglaucomatous and local antiphlogistic therapy on the intraocular pressure].

Authors:  I Oberacher-Velten; F Zeman; F Lehmann; T Barth; P Peters; H Helbig; R Greslechner
Journal:  Ophthalmologe       Date:  2017-07       Impact factor: 1.059

5.  Risk factors of ocular hypertension and glaucoma. The Casteldaccia Eye Study.

Authors:  F Ponte; G Giuffré; R Giammanco; G Dardanoni
Journal:  Doc Ophthalmol       Date:  1994       Impact factor: 2.379

6.  Effects of topical corticosteroid administration on intraocular pressure in normal and glaucomatous cats.

Authors:  Allyson A Gosling; Julie A Kiland; Lauren E Rutkowski; Adam Hoefs; Norman Matthew Ellinwood; Gillian J McLellan
Journal:  Vet Ophthalmol       Date:  2016-02-15       Impact factor: 1.644

7.  Dexamethasone increases pigment epithelium-derived factor in perfused human eyes.

Authors:  Elizabeth M Perruccio; Laura Leigh S Rowlette; Nuria Comes; Silvia Locatelli-Hoops; Luigi Notari; S Patricia Becerra; Teresa Borrás
Journal:  Curr Eye Res       Date:  2008-05       Impact factor: 2.424

8.  Ocular hypertensive response to topical dexamethasone ointment in children.

Authors:  Yoon Jung Lee; Chan Yi Park; Kyung In Woo
Journal:  Korean J Ophthalmol       Date:  2006-09

Review 9.  Trabecular meshwork stiffness in glaucoma.

Authors:  Ke Wang; A Thomas Read; Todd Sulchek; C Ross Ethier
Journal:  Exp Eye Res       Date:  2016-07-19       Impact factor: 3.467

10.  Presence of an established calcification marker in trabecular meshwork tissue of glaucoma donors.

Authors:  Wei Xue; Núria Comes; Teresa Borrás
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-07       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.